Turk Ilac ve Serum Sanayi AS Cash Flow Conversion Efficiency
Turk Ilac ve Serum Sanayi AS cash flow conversion efficiency. Based on the latest financial reports, Turk Ilac ve Serum Sanayi AS (TRILC) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL44.50 Million ≈ $996.76K USD) by net assets (TL1.91 Billion ≈ $42.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Turk Ilac ve Serum Sanayi AS (2018–2024)
Cash flow conversion efficiency of Turk Ilac ve Serum Sanayi AS from 2018 to 2024. This chart illustrates how Turk Ilac ve Serum Sanayi AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Turk Ilac ve Serum Sanayi AS for real-time trading data and today's change.
Turk Ilac ve Serum Sanayi AS Cash Flow Conversion Ratio Explained
Turk Ilac ve Serum Sanayi AS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Turk Ilac ve Serum Sanayi AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Turk Ilac ve Serum Sanayi AS ranked by their cash flow conversion efficiency. Also see Turk Ilac ve Serum Sanayi AS market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Energy Focu
NASDAQ:EFOI
|
-0.245x |
|
Currys PLC
LSE:CURY
|
0.094x |
|
Matichon Public Company Limited
BK:MATI
|
-0.002x |
|
Sanginita Chemicals Limited
NSE:SANGINITA
|
0.017x |
|
Superhouse Limited
NSE:SUPERHOUSE
|
0.110x |
|
High-Tech Metals Ltd
AU:HTM
|
-0.072x |
|
UMS Holdings Bhd
KLSE:7137
|
0.018x |
|
Seojin Automotive Co.Ltd
KQ:122690
|
0.107x |
Annual Cash Flow Conversion Efficiency for Turk Ilac ve Serum Sanayi AS (2018–2024)
The table below shows the annual cash flow conversion efficiency of Turk Ilac ve Serum Sanayi AS from 2018 to 2024. Review cash generation quality of Turk Ilac ve Serum Sanayi AS to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | TL1.92 Billion ≈ $43.09 Million |
TL-378.48 Million ≈ $-8.48 Million |
-0.197x | -185.55% |
| 2023-12-31 | TL1.78 Billion ≈ $39.76 Million |
TL408.19 Million ≈ $9.14 Million |
0.230x | +1193.03% |
| 2022-12-31 | TL564.69 Million ≈ $12.65 Million |
TL-11.88 Million ≈ $-266.08K |
-0.021x | +90.49% |
| 2021-12-31 | TL324.08 Million ≈ $7.26 Million |
TL-71.67 Million ≈ $-1.61 Million |
-0.221x | -198.67% |
| 2020-12-31 | TL148.13 Million ≈ $3.32 Million |
TL33.20 Million ≈ $743.59K |
0.224x | +9.86% |
| 2019-12-31 | TL65.28 Million ≈ $1.46 Million |
TL13.32 Million ≈ $298.28K |
0.204x | -66.57% |
| 2018-12-31 | TL62.47 Million ≈ $1.40 Million |
TL38.13 Million ≈ $853.93K |
0.610x | -- |
About Turk Ilac ve Serum Sanayi AS
Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in Turkey. It also offers bulb, biological, and serum products, as well as medical devices. Turk Ilac Ve Serum Sanayi Anonim Sirketi was founded in 2010 and is headquartered in Anka… Read more